Statin for Preventing Hepatocellular Carcinoma Recurrence After Curative Treatment

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

January 3, 2017

Primary Completion Date

January 31, 2025

Study Completion Date

January 31, 2027

Conditions
HepatoCellular Carcinoma
Interventions
DRUG

Atorvastatin

Atorvastatin 10mg daily

DRUG

Placebo Oral Tablet

Placebo one tablet daily

Trial Locations (6)

Unknown

Ditmanson Medical Foundation Chiayi Christian Hospital, Chiayi City

E-DA Hospital, Kaohsiung City

Taichung Veterans General Hospital, Taichung

Tainan Municipal Hospital, Tainan City

Mackay Memorial Hospital, Taipei

National Taiwan University Hospital Yun-Lin Branch, Yunlin

All Listed Sponsors
collaborator

E-DA Hospital

OTHER

collaborator

National Taiwan University Hospital

OTHER

collaborator

Taichung Veterans General Hospital

OTHER

collaborator

Mackay Memorial Hospital

OTHER

collaborator

Tainan Municipal Hospital

OTHER

collaborator

National Cheng-Kung University Hospital

OTHER

collaborator

Chi Mei Medical Hospital

OTHER

lead

Chiayi Christian Hospital

OTHER